Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Stallard

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
BMC Health Services Research|March 20, 2012
Health service use in families where children enter public care: a nested case control study using the General Practice Research DatabaseDouglas E Simkiss, Nicholas J Spencer, Nigel Stallard, et al.
The Lancet. Oncology|March 31, 2007
A newly devised scoring system for prediction of mortality in patients with colorectal cancer: a prospective studyAli M Ferjani, Damian Griffin, Nigel Stallard, et al.
Statistics in Medicine|February 27, 2009
Optimal choice of the number of treatments to be included in a clinical trialNigel Stallard, Martin Posch, Tim Friede, et al.
Statistical Methods in Medical Research|March 15, 2023
Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trialBenjamin Duputel, Nigel Stallard, François Montestruc, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Journal of Biopharmaceutical Statistics|July 19, 2005
A practical comparison of group-sequential and adaptive designsPatrick J Kelly, M Roshini Sooriyarachchi, Nigel Stallard, et al.
Statistics in Medicine|November 24, 2022
Adjusting for treatment selection in phase II/III clinical trials with time to event dataJosephine N Khan, Peter K Kimani, Ekkehard Glimm, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Repeated challenge with prion disease: the risk of infection and impact on incubation periodMike B Gravenor, Nigel Stallard, Robert Curnow, et al.
Health Economics|November 26, 2021
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicinesDaniel Gallacher, Nigel Stallard, Peter Kimani, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
BMC Health Services Research|March 20, 2012
Health service use in families where children enter public care: a nested case control study using the General Practice Research DatabaseDouglas E Simkiss, Nicholas J Spencer, Nigel Stallard, et al.
The Lancet. Oncology|March 31, 2007
A newly devised scoring system for prediction of mortality in patients with colorectal cancer: a prospective studyAli M Ferjani, Damian Griffin, Nigel Stallard, et al.
Statistics in Medicine|February 27, 2009
Optimal choice of the number of treatments to be included in a clinical trialNigel Stallard, Martin Posch, Tim Friede, et al.
Statistical Methods in Medical Research|March 15, 2023
Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trialBenjamin Duputel, Nigel Stallard, François Montestruc, et al.
Statistics in Medicine|January 7, 2006
Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugsPatrick Kelly, Nigel Stallard, Yinghui Zhou, et al.
Journal of Biopharmaceutical Statistics|July 19, 2005
A practical comparison of group-sequential and adaptive designsPatrick J Kelly, M Roshini Sooriyarachchi, Nigel Stallard, et al.
Statistics in Medicine|November 24, 2022
Adjusting for treatment selection in phase II/III clinical trials with time to event dataJosephine N Khan, Peter K Kimani, Ekkehard Glimm, et al.
Statistics in Medicine|November 6, 2007
Sequentially testing for a gene-drug interaction in a genomewide analysisPatrick Kelly, Yinghui Zhou, John Whitehead, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Repeated challenge with prion disease: the risk of infection and impact on incubation periodMike B Gravenor, Nigel Stallard, Robert Curnow, et al.
Health Economics|November 26, 2021
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicinesDaniel Gallacher, Nigel Stallard, Peter Kimani, et al.
Pageof 16